… , fondaparinux, heparin, bivalirudin, enoxaparin, dalteparin, … for apixaban compared to
enoxaparin in decreasing mortality [… survival and higher mortality risk in COVID-19 patients on …

… use of heparinoid anticoagulants, ie unfractionated heparin and low molecular weight …
with enoxaparin for COVID-19 patients, they specified the prophylactic dosage of LMWH as …

… that mortality in hospitalized patients with COVID-19 might be … with therapeutic-dose
enoxaparin and apixaban, and major … -weight heparin in patients hospitalized with COVID-19. …

… Heparin inhibits inflammation not only by its anticoagulant … risk of severe disease and mortality
in patients with COVID-19. … then thromboprophylaxis with either apixaban (Eliquis) 2.5 mg …

… events or mortality among COVID-19 patients. … anticoagulant for thromboprophylaxis in
COVID-19 patients is scarce, unfractionated heparin (UFH) and low-molecular-weight heparin (…

… the association between anticoagulant or heparin and the survival of COVID-19 patients, (4,…
Prophylactic and therapeutic doses heparin or enoxaparin Characteristic of data and patient …

… therapeutic dose anticoagulation with a heparin formulation … in mortality in ICU COVID-19
patients over no anticoagulation in … COVID) comparing enoxaparin with apixaban in this patient …

… of anticoagulation therapy, treatment for COVID-19 infection, … heparin may reduce mortality
among hospitalized COVID-19 … , and apixaban on mortality. J Thromb Haemost. 2020;120:…

… d Oral anticoagulants included warfarin, apixaban, … enoxaparin in hospitalized patients with
COVID-19 [14], and the … inhibitor to a therapeutic dose of heparin did not improve survival [20]…

… of anticoagulation (AC), LMWH vs unfractionated heparin (UFH), and AC level, prophylactic
vs therapeutic, can have an impact on patient mortality … anticoagulation with enoxaparin 1 mg/…